JP2019526543A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019526543A5 JP2019526543A5 JP2019506143A JP2019506143A JP2019526543A5 JP 2019526543 A5 JP2019526543 A5 JP 2019526543A5 JP 2019506143 A JP2019506143 A JP 2019506143A JP 2019506143 A JP2019506143 A JP 2019506143A JP 2019526543 A5 JP2019526543 A5 JP 2019526543A5
- Authority
- JP
- Japan
- Prior art keywords
- agent
- cancer
- antigen
- patient
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003795 chemical substances by application Substances 0.000 claims 3
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 239000000427 antigen Substances 0.000 claims 1
- 102000036639 antigens Human genes 0.000 claims 1
- 108091007433 antigens Proteins 0.000 claims 1
- 239000002105 nanoparticle Substances 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022131006A JP2022161992A (ja) | 2016-08-05 | 2022-08-19 | 癌治療のための修飾抗体－アルブミンナノ粒子複合体 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662371668P | 2016-08-05 | 2016-08-05 | |
| US62/371,668 | 2016-08-05 | ||
| US201662409830P | 2016-10-18 | 2016-10-18 | |
| US62/409,830 | 2016-10-18 | ||
| PCT/US2017/045643 WO2018027205A1 (en) | 2016-08-05 | 2017-08-04 | Modified antibody-albumin nanoparticle complexes for cancer treatment |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022131006A Division JP2022161992A (ja) | 2016-08-05 | 2022-08-19 | 癌治療のための修飾抗体－アルブミンナノ粒子複合体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019526543A JP2019526543A (ja) | 2019-09-19 |
| JP2019526543A5 true JP2019526543A5 (cg-RX-API-DMAC7.html) | 2020-09-17 |
| JP7158372B2 JP7158372B2 (ja) | 2022-10-21 |
Family
ID=59677326
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019506143A Active JP7158372B2 (ja) | 2016-08-05 | 2017-08-04 | 癌治療のための修飾抗体－アルブミンナノ粒子複合体 |
| JP2022131006A Pending JP2022161992A (ja) | 2016-08-05 | 2022-08-19 | 癌治療のための修飾抗体－アルブミンナノ粒子複合体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022131006A Pending JP2022161992A (ja) | 2016-08-05 | 2022-08-19 | 癌治療のための修飾抗体－アルブミンナノ粒子複合体 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20210267930A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3493854B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7158372B2 (cg-RX-API-DMAC7.html) |
| KR (2) | KR102482503B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN109922836A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2017307618A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3032947A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL264598A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2019001517A (cg-RX-API-DMAC7.html) |
| RU (1) | RU2019105550A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2018027205A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2707030B1 (en) | 2011-05-09 | 2020-02-19 | Mayo Foundation For Medical Education And Research | Cancer treatments |
| WO2014055415A1 (en) | 2012-10-01 | 2014-04-10 | Mayo Foundation For Medical Education And Research | Cancer treatments |
| AU2015274408A1 (en) | 2014-06-13 | 2017-01-12 | Mayo Foundation For Medical Education And Research | Treating lymphomas |
| EA201692502A1 (ru) | 2014-06-16 | 2017-09-29 | Мэйо Фаундейшн Фор Медикал Эдьюкейшн Энд Рисерч | Лечение миелом |
| US9446148B2 (en) | 2014-10-06 | 2016-09-20 | Mayo Foundation For Medical Education And Research | Carrier-antibody compositions and methods of making and using the same |
| TW201707725A (zh) | 2015-08-18 | 2017-03-01 | 美國馬友醫藥教育研究基金會 | 載體－抗體組合物及其製造及使用方法 |
| TW201713360A (en) | 2015-10-06 | 2017-04-16 | Mayo Foundation | Methods of treating cancer using compositions of antibodies and carrier proteins |
| WO2017120501A1 (en) | 2016-01-07 | 2017-07-13 | Mayo Foundation For Medical Education And Research | Methods of treating cancer with interferon |
| US11878061B2 (en) | 2016-03-21 | 2024-01-23 | Mayo Foundation For Medical Education And Research | Methods for improving the therapeutic index for a chemotherapeutic drug |
| CA3018341A1 (en) | 2016-03-21 | 2017-09-28 | Mayo Foundation For Medical Education And Research | Methods for reducing toxicity of a chemotherapeutic drug |
| US10618969B2 (en) | 2016-04-06 | 2020-04-14 | Mayo Foundation For Medical Education And Research | Carrier-binding agent compositions and methods of making and using the same |
| KR102462041B1 (ko) | 2016-09-01 | 2022-11-02 | 메이오 파운데이션 포 메디칼 에쥬케이션 앤드 리써치 | 암 치료용 담체－ｐｄ－ｌ１ 결합제 조성물 |
| CN109843336A (zh) | 2016-09-01 | 2019-06-04 | 梅约医学教育与研究基金会 | 用于靶向t细胞癌症的方法和组合物 |
| EP3509635A1 (en) | 2016-09-06 | 2019-07-17 | Vavotar Life Sciences LLC | Methods of treating triple-negative breast cancer using compositions of antibodies and carrier proteins |
| JP7025412B2 (ja) | 2016-09-06 | 2022-02-24 | マヨ ファウンデーション フォー メディカル エデュケーション アンド リサーチ | パクリタキセル－アルブミン－結合剤組成物並びに該組成物の使用及び製造方法 |
| CN109843924A (zh) | 2016-09-06 | 2019-06-04 | 梅约医学教育与研究基金会 | 治疗表达pd-l1的癌症的方法 |
| US11531030B2 (en) | 2017-04-21 | 2022-12-20 | Mayo Foundation For Medical Education And Research | Polypeptide-antibody complexes and uses thereof |
| EP3749331A4 (en) * | 2018-02-06 | 2021-08-04 | Mayo Foundation for Medical Education and Research | ANTIBODY PEPTIDE COMPLEX AND THEIR USES |
| JP7308507B2 (ja) * | 2019-01-31 | 2023-07-14 | Ｓｐｉｂｅｒ株式会社 | 組換え構造タンパク質の製造方法及び分析方法、並びにタンパク質成形体の製造方法 |
| CN116687833A (zh) * | 2023-07-24 | 2023-09-05 | 中山大学 | 一种含有抗体偶联白蛋白紫杉醇纳米药物的可溶性微针及其制备方法和应用 |
| CN119405830B (zh) * | 2024-09-19 | 2025-09-05 | 北京大学 | 一种纳米抗体偶联物及其制备方法和应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8853260B2 (en) | 1997-06-27 | 2014-10-07 | Abraxis Bioscience, Llc | Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof |
| SI1585548T1 (sl) | 2002-12-09 | 2018-11-30 | Abraxis Bioscience, Llc | Sestave in metode odmerjanja farmakoloških sredstev |
| ES2529660T3 (es) * | 2004-05-14 | 2015-02-24 | Abraxis Bioscience, Llc | Métodos de tratamiento en los que se utilizan las proteínas de unión a albúmina como dianas |
| AU2005286662B2 (en) * | 2004-09-23 | 2011-10-06 | Vasgene Therapeutics, Inc. | Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| US20070166388A1 (en) * | 2005-02-18 | 2007-07-19 | Desai Neil P | Combinations and modes of administration of therapeutic agents and combination therapy |
| SI2301531T1 (sl) | 2005-02-18 | 2018-11-30 | Abraxis Bioscience, Llc | Kombinacije in načini dajanja terapevtskih sredstev in kombinacijska terapija |
| NZ606480A (en) * | 2008-12-05 | 2014-08-29 | Abraxis Bioscience Llc | Albumin binding peptide-mediated disease targeting |
| CN102458471A (zh) * | 2009-05-28 | 2012-05-16 | 葛兰素集团有限公司 | 用于治疗或预防眼病的TNFα拮抗剂和VEGF拮抗剂的组合 |
| EP2707030B1 (en) | 2011-05-09 | 2020-02-19 | Mayo Foundation For Medical Education And Research | Cancer treatments |
| WO2014055415A1 (en) * | 2012-10-01 | 2014-04-10 | Mayo Foundation For Medical Education And Research | Cancer treatments |
| AU2015274408A1 (en) * | 2014-06-13 | 2017-01-12 | Mayo Foundation For Medical Education And Research | Treating lymphomas |
| US9446148B2 (en) | 2014-10-06 | 2016-09-20 | Mayo Foundation For Medical Education And Research | Carrier-antibody compositions and methods of making and using the same |
| CN113599534A (zh) * | 2014-10-06 | 2021-11-05 | 梅约医学教育与研究基金会 | 载体-抗体组合物及其制备和使用方法 |
| US11041014B2 (en) * | 2016-10-28 | 2021-06-22 | S & K Biopharma, Inc. | Lactoferrin/albumin fusion protein and production method therefor |
-
2017
- 2017-08-04 AU AU2017307618A patent/AU2017307618A1/en not_active Abandoned
- 2017-08-04 KR KR1020197006118A patent/KR102482503B1/ko active Active
- 2017-08-04 CA CA3032947A patent/CA3032947A1/en active Pending
- 2017-08-04 JP JP2019506143A patent/JP7158372B2/ja active Active
- 2017-08-04 CN CN201780062131.4A patent/CN109922836A/zh active Pending
- 2017-08-04 EP EP17754896.3A patent/EP3493854B1/en active Active
- 2017-08-04 MX MX2019001517A patent/MX2019001517A/es unknown
- 2017-08-04 WO PCT/US2017/045643 patent/WO2018027205A1/en not_active Ceased
- 2017-08-04 KR KR1020227045346A patent/KR20230006037A/ko not_active Withdrawn
- 2017-08-04 US US16/323,377 patent/US20210267930A1/en not_active Abandoned
- 2017-08-04 RU RU2019105550A patent/RU2019105550A/ru unknown
-
2019
- 2019-02-03 IL IL264598A patent/IL264598A/en unknown
-
2022
- 2022-08-19 JP JP2022131006A patent/JP2022161992A/ja active Pending
-
2023
- 2023-01-11 US US18/153,286 patent/US20240058296A1/en not_active Abandoned